(A) Injection schematic and representative image. Retrogradely transported CTBs were injected into MD (green) and VM (red) of wild-type mice, followed by imaging in PFC. Grayscale image shows DAPI labeling. Scale bar: 1000 μm.
(B) Representative image (left) and quantification (right) of distribution of MD-projecting (green), VM-projecting (red), and dual-projecting (yellow) CT neurons across layers of prelimbic PFC. Image is from the same animal as in (A). Dashed lines: Layer boundaries. Scale bar: 100 μm.
(C) Summary of fraction of L5 and L6 CT neurons that project to MD, VM, or both nuclei.
(D) Injection schematic. Retrograde CAV2-Cre was injected into MD (as shown) or VM of wild-type mice, followed by anterograde AAV expressing Cre-dependent YFP and red retrobeads into PFC. Arrows indicate axon direction for projection-specific labeling.
(E) Representative images showing anterograde PFC axon (green) and retrogradely labeled TC neurons in the thalamus (red) from mice in which CAV2-Cre was injected in MD (left) or VM (right). Grayscale images show DAPI labeling. Dashed boxes are magnified in side images. Scale bars: 1000 μm or 200 μm.
(F) Representative images showing labeling of PFC neurons and projections following injections shown in (D). Left: Retrogradely labeled CT neurons in both L5 and L6 of prelimbic PFC (bregma +2.1 mm). Middle & right: CT axons in subcortical targets such as the internal capsule (IC, bregma −2.0 mm) and pons (bregma −4.3 mm), but not BLA (bregma −2.0 mm). Scale bars: 1000 μm or 100 μm.
Values are mean ± SEM.
See also
Figure S3